Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013 (2013), Article ID 576486, 8 pages
http://dx.doi.org/10.1155/2013/576486
Research Article

CTLA-4 Expression and Polymorphisms in Lung Tissue of Patients with Diagnosed Non-Small-Cell Lung Cancer

1Department of General and Oncological Pulmonology, 1st Chair of Internal Diseases, Medical University of Lodz, Kopcińskiego 22, 90-153 Łódź, Poland
2Department of Molecular Bases of Medicine, 1st Chair of Internal Diseases, Medical University of Lodz, Pomorska 251, 92-213 Łódź, Poland
3Department of Pneumology and Allergology, 1st Chair of Internal Diseases, Medical University of Lodz, Kopcińskiego 22, 90-153 Łódź, Poland
4Department of Chest Surgery, General and Oncological Surgery University Hospital No. 2, Medical University of Lodz, Żeromskiego 113, 90-710 Łódź, Poland

Received 23 April 2013; Revised 19 June 2013; Accepted 23 June 2013

Academic Editor: Carlo Jose Freire de Oliveira

Copyright © 2013 Adam Antczak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [13 citations]

The following is the list of published articles that have cited the current article.

  • Dor Mohammad Kordi-Tamandani, Shahrbbanou Karimi Davani, Taybeh Baranzehi, and Simin Hemati, “Analysis of Promoter Methylation, Polymorphism and Expression Profile of Cytotoxic T-Lymphocyte-Associated Antigen-4 in Patients with Gastric Cancer,” Journal of Gastrointestinal and Liver Diseases, vol. 23, no. 3, pp. 249–253, 2014. View at Publisher · View at Google Scholar
  • Chang-qing Chen, Zhou-li Li, Bing-yi Shi, Ming Cai, Yu-bo Zhao, Bo-quan Jin, Chun-yan Wang, Yong Han, Li Xiao, and Wen-qiang Zhou, “Cytotoxic T lymphocyte-associated antigen 4 in acute rejection after renal transplantation,” Chinese Journal of Tissue Engineering Research, vol. 18, no. 5, pp. 730–735, 2014. View at Publisher · View at Google Scholar
  • Gang Li, Fengjun Shi, Jingchen Liu, and Ye Li, “The effect of CTLA-4 A49G polymorphism on rheumatoid arthritis risk: a meta-analysis,” Diagnostic Pathology, vol. 9, no. 1, pp. 157, 2014. View at Publisher · View at Google Scholar
  • Lei Deng, Balazs Gyorffy, Feifei Na, Baoqing Chen, Jie Lan, Jianxin Xue, Lin Zhou, and You Lu, “Association of PDCD1 and CTLA-4 Gene Expression with Clinicopathological Factors and Survival in Non–Small-Cell Lung Cancer,” Journal of Thoracic Oncology, vol. 10, no. 7, pp. 1020–1026, 2015. View at Publisher · View at Google Scholar
  • Alexander Faje, “Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights,” Pituitary, 2015. View at Publisher · View at Google Scholar
  • Zhiming Dai, Chuanjie Feng, Wanggang Zhang, Jie Liu, Xingmei Cao, Hui Zhang, Yuhong Liu, Meng Wang, Xinghan Liu, and Zhijun Dai, “Lack of association between cytotoxic T-lymphocyte antigen-4 gene polymorphisms and lymphoid malignancy risk: evidence from a meta-analysis,” Annals of Hematology, 2016. View at Publisher · View at Google Scholar
  • Srdjan Tanasilovic, Svetlana Popadic, Ljiljana Medenica, and Dusan Popadic, “Pemphigus Vulgaris and Pemphigus Foliaceus Determined by CD86 and CTLA4 Polymorphisms,” Clinics in Dermatology, 2016. View at Publisher · View at Google Scholar
  • Silvio Roncella, Stefania Laurent, Vincenzo Fontana, Paola Ferro, Maria Cristiana Franceschini, Sandra Salvi, Serena Varesano, Simona Boccardo, Antonella Vigani, Anna Morabito, Pier Aldo Canessa, Ugo Giannoni, Ilan Rosenberg, Alessandro Valentino, Franco Fedeli, Domenico Franco Merlo, Marcello Ceppi, Salvatore Riggio, Massimo Romani, Daniele Saverino, Alessandro Poggi, and Maria Pia Pistillo, “CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor,” Cancer Immunology, Immunotherapy, 2016. View at Publisher · View at Google Scholar
  • Christopher G. England, Douglas G. McNeel, Weibo Cai, and Emily B. Ehlerding, “Molecular imaging of immunotherapy targets in cancer,” Journal of Nuclear Medicine, vol. 57, no. 10, pp. 1487–1492, 2016. View at Publisher · View at Google Scholar
  • Erna-Elise Paulsen, Thomas K. Kilvaer, Mehrdad Rakaee, Elin Richardsen, Sigurd M. Hald, Sigve Andersen, Lill-Tove Busund, Roy M. Bremnes, and Tom Donnem, “CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases,” Cancer Immunology, Immunotherapy, 2017. View at Publisher · View at Google Scholar
  • Mei Chen, Shenglong Xie, Chun Wan, Ni Zeng, Yanqiu Wu, Jiangyue Qin, Yongchun Shen, and Fuqiang Wen, “Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion,” Postgraduate Medicine, pp. 1–5, 2017. View at Publisher · View at Google Scholar
  • Emily B. Ehlerding, Christopher G. England, Rebecca L. Majewski, Hector F. Valdovinos, Dawei Jiang, Glenn Liu, Douglas G. McNeel, Robert J. Nickles, and Weibo Cai, “ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer,” Molecular Pharmaceutics, 2017. View at Publisher · View at Google Scholar
  • Hai Chen, Xiaodong Qi, Xue Bai, Ping Qiu, and Bin Chen, “Role of CD152 genetic polymorphisms in the susceptibility to breast cancer,” Oncotarget, vol. 8, no. 16, pp. 26679–26686, 2017. View at Publisher · View at Google Scholar